UK markets close in 1 hour 20 minutes

Pharma Mar, S.A. (0RC6.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
73.87+0.83 (+1.14%)
As of 06:20PM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.08
52-week change 3-56.47%
S&P500 52-week change 322.64%
52-week high 374.38
52-week low 329.46
50-day moving average 333.42
200-day moving average 351.08

Share statistics

Avg vol (3-month) 36.87k
Avg vol (10-day) 34.01k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 813.71M
% held by insiders 121.39%
% held by institutions 17.70%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.65
Trailing annual dividend yield 30.89%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.083333:1
Last split date 322 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.72%
Operating margin (ttm)-12.63%

Management effectiveness

Return on assets (ttm)-0.65%
Return on equity (ttm)0.55%

Income statement

Revenue (ttm)158.15M
Revenue per share (ttm)8.84
Quarterly revenue growth (yoy)-20.30%
Gross profit (ttm)N/A
EBITDA -1.15M
Net income avi to common (ttm)1.14M
Diluted EPS (ttm)5.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)162.56M
Total cash per share (mrq)9.22
Total debt (mrq)43.67M
Total debt/equity (mrq)22.58%
Current ratio (mrq)2.63
Book value per share (mrq)10.97

Cash flow statement

Operating cash flow (ttm)-13.45M
Levered free cash flow (ttm)-12.59M